polypeptides (T. W. LeBien, unpublished findings) . The failure of TA-1 to precipitate CDllb indicates that TA-1 recognizes the ot, rather than the /3, subunit of LFA-1 . The IgG content of ascites was quantified by radial immunodiffusion (18) in agar gels containing 0.01 vol of rabbit anti-mouse IgG antiserum (Miles Laboratories, Inc., Naperville, IL) . Homogeneous antibodies were prepared from ascites by adherence to protein A-agarose at pH 8.0 and elution at low pH (19) .
Reagents . rIFN-,y (106 U/ml) was from Amgen Biologicals, Thousand Oaks, CA. Medium 199, RPMI 1640, and HBSS were from Gibco Laboratories, Grand Island, NY; gentamycin was from M. A. Bioproducts, Walkerville, MD; and FCS was from HyClone Laboratories, Logan, UT. Culture solutions and supernatants were assayed with a chromogenic Limulus amoebocyte lysate assay (M. A. Bioproducts) to insure that LPS content was 50.01 ng/ml .
Cells. Human peripheral blood from healthy volunteers was drawn into plastic vials containing acid-citrate-dextrose (NIH formula A; Fenwal Laboratories, Deerfield, IL), and mononuclear cells were purified by Ficoll-Hypaque centrifugation . The mononuclear cells (2 x 105 in 200 lil RPMI 1640 medium with 10% FCS) were incubated in 96-well tissue culture plates (Becton Dickinson & Co., Oxnard, CA) for 1 h at 37°C. Nonadherent material was decanted and the wells were washed with RPMI 1640 at 37°C . The adherent cells (N0 .5 x 105/well), -96% monocytes as judged by esterase staining (20) , were cultured in RPMI 1640 with 10% FCS and 50,ug/ml gentamycin for 24 h and were washed with RPMI 1640. Platelet contamination, quantified at this point by microscopic examination, was 58 platelets/100 monocytes .
Monocyte Activation . mAb (ascites or purified IgG) or IFN-'Y in RPMI 1640 containing 10% FCS were added to washed 1-d-old adherent monocytes, which were then cultured for 0.5-48 h.
Hydrogen Peroxide Assay. Secretion of H202 in response to PMA was measured by the modified scopoletin fluorescent assay (21) . The monolayers were incubated with 7 'UM scopoletin, 20 Etg/ml horseradish peroxidase, 65 ng/ml PMA, and 1 mM NaN3 in a volume of 200 p.l. DNA content, determined in parallel wells, as described (22) , indicated that none ofthe experimental treatments altered the number ofcells per well. Hydrogen peroxide production was expressed as ng H202/Fig DNA/h. AssayforMonocyte Aggregation. All plates were assigned coded identification by an individual not otherwise involved in the study. Wells were scored for aggregates, defined as the association of 310 cells, using a Nikon phase contrast microscope .
Results
Anti-CD43 mAb LIO Induces Hydrogen Peroxide Production in Human Monocytes. Isolated human blood monocytes were allowed to mature in culture for 1 d, then treated with the anti-CD43 mAb L10 for 48 h . Hydrogen peroxide release measured in the presence ofthe triggering agent PMA was increased five-to sevenfold in L10-treated monocytes in comparison with monocytes treated without antibody or with subclassmatched irrelevant antibody (M12 mAb) (Fig. 1) . Optimal hydrogen peroxide-producing capacity was induced by 15 ttg/ml L10, and higher levels had no additional effect . L10 used in these experiments was pure IgG, indicating that its action is not attributable to other components. The level of peroxide-producing capacity induced by optimal L10 mAb concentrations (1.6 ± 0.3 nmol H202/tig DNA/h) was comparable with that induced by optimal levels of rIFN-y (1.3 ± 0.4 nmol H202/p,g DNA/h) (mean ± SE ofsix experiments ; e.g., Fig . 1 ). As previously shown for IFN-T-activated monocytes, L10-treated monocytes require the triggering agent PMA to be present in the hydrogen peroxide assay (not shown) .
Time Course of Enhancement of Hydrogen Peroxide Capacity Induced by L10 mAb. L10 induction of increased hydrogen peroxide-producing capacity of monocytes is a timedependent reaction with maximum capacity reached after 24 h with 15 hg/ml L10 Fig. 2) . In contrast, in IFN-y-treated monocytes, maximum peroxide production was reached after 48 h with 200 U/ml (Fig. 2) . Further increase of the IFN-y concentration did not shorten the time (not shown). Thus, maximum hydrogen peroxide-producing capacity is reached after 24 h of treatment of monocytes with optimal L10 concentration or 48 h with optimal IFN-y .
Anti-CD43 mAb Induces Homotyßic Adhesion of Monocytes. The adherence properties of 1,10-treated monocytes were also examined, since IFN-y-induced monocyte activation is known to proceed via a stage involving homotypic cell adhesion (23) . When 1-d-old adherent monocytes were treated with L10 for 24 h, increased numbers of aggregates were found relative to monocytes treated with subclass-matched irrelevant antibody (Fig. 3 ) or monocytes incubated without antibody (not shown). The increase of monocyte aggregation was dependent on L10 concentration with maximal aggregation at 5-10 hg/ml; 20 and 40 /Ag/ml L10 were partially inhibitory (Fig. 3) . The level of monocyte aggregation induced by L10 mAb was comparable with that induced by IFN-y (shown below) .
Time Course of Monocyte Aggregation Induced by the Anti-CD43 Antibody L10. Monocyte aggregation induced by L10 is a time-dependent process, with significant aggregation detected after 1 and 4 h, and maximal aggregation reached at 8 h of L10 treatment (Fig. 4) . The requirement for 1-8-h incubation strongly suggests that L10 does not function solely as a crosslinking agent. L10-induced monocyte aggregation remained maximal at 12, 24, and 48 h (Fig . 4) . In contrast, monocyte aggregation induced by IFN-1' is nondetectable at 12 h and maximal at 24 h (Fig . 4) . Role induction of aggregation by L10 was almost completely abrogated (Table I ). The capacity of the cells to undergo L10-induced homotypic adhesion was restored by addition of 1 mM Mg2+ ; addition of Cat+ had no effect . Thus, Mg2+ is required to support L10-induced monocyte aggregation, a finding inconsistent with mechanisms in which L10 acts solely as a crosslinking agent.
The Anti-LFA-1 Antibody TA-1 Inhibits Monocyte Aggregation Induced by the Anti-CD43 Antibody L10. IFN-, y -induced homotypic adhesion of monocytes was shown to in- Adherent monocytes that had been cultured for 1 d in complete medium, were incubated for 2 h in HBSS + FCS (complete medium) or Mg 2 +/Ca 2 +-free HBSS + dialyzed FCS (depleted medium) . L10 ascites diluted 1 :100 in complete or depleted medium were added, and cell aggregation was evaluated after a further 4-h incubation . Where indicated, 1 mM Mg2+ and/or Ca t + was added to depleted cell cultures simultaneously with L10 addition . The data are the means ± SE of quadruplicate determinations . Homotypic adhesion of monocytes induced by L10 rnAb is inhibited by TA-1 mAb. 1-d-old adherent monocytes were cultured for the indicated time with medium alone (O), TA-1 mAb ascites at 1:10 dilution (A), 10 hg/ml of L10 IgG ("), and L10 + TA-1 (A). The number of aggregates/well are means ± SE of triplicate determinations . Similarresults were obtained with L10 mAb at 20 ttg/ml (not shown).
volve the heterodimeric surface molecule LFA-1 (CDlla/CD18) (23) . To determine whether LFA-1 is involved in LIO-induced homotypic adhesion, the monocytes were treated with L10 mAb in the presence of the anti-LFA-la (anti-CDlla) mAb TA-1 . TA-1 mAb completely abrogated the induction of monocyte aggregation by 10 or 20 ug/ml L10 mAb (Fig . 5) . The mAb 44, an anti-Mol-a (anti-CD11b) antibody, at the same concentration, had no effect on 1,10-induced monocyte aggregation (not shown) . The mAb 60 .3 (anti-CD18) directed against the common (3 subunit of Mol and LFA-1 caused slight inhibition of 1,10-induced monocyte aggregation (not shown) . These findings indicate that L10-induced monocyte aggregation is a Mgt+ -requiring process, that like IFN-y-induced monocyte aggregation, involves LFA-1 surface molecules .
Discussion
The present study demonstrates that L10, an mAb that binds to sialophorin (CD43), induces increased hydrogen peroxide-producing capacity and homotypic adhesion of human monocytes, two characteristics associated with the activated state of these cells. The requirement for Mgt+ and 1-8-h incubation strongly indicates that L10-induced monocyte aggregation is not a simple case of antibody crosslinking of cells. In direct comparisons, the extent of L10-induced enhancement of hydrogen peroxide-producing capacity and homotypic adhesion were found to be comparable with the effects induced by the prototypic monocyte-activating agent IFN-y.
The finding that Mgt' depletion abrogates, and Mgt' reconstitution restores, 1,10-induced monocyte aggregation suggested the involvement of adhesion molecules of the Leu-CAM family. These are heterodimer surface glycoproteins consisting of CD18 and either CD11a (LFA-1), CD11b (Mol, Mac-1), or CD11c (p150,95) (reviewed in reference 24). LFA-1 has been shown to mediate heterotypic and homotypic interactions of leukocytes, including IFN-y-induced aggregation of monocytes (23) . TA-1, a LFA-la mAb, reduced L10-induced aggregation to baseline levels, indicating that LFA-1 is instrumental in L10-induced monocyte aggregation . An anti-CD18 mAb, 60 .3 (anti-a chain), had a slight inhibitory effect on L10-induced monocyte aggregation. A previous study showed that IFN-y-induced monocyte aggregation, like L10-induced monocyte aggregation, was inhibited completely by anti-LFA-Ici mAb, but only partially by an anti-CD18 mAb that was completely inhibitory in a lymphocyte system (23) . The lesser sensitivity of IFN-y-induced monocyte aggregation to inhibition by anti-CD18 mAb was attributed to the presence on monocytes of multiple CD18 heterodimers (23) .
We do not know whether there is any relatedness of the findings reported here, i.e., activation of monocytes by anti-CD43 mAb, and an earlier study in the mouse system demonstrating activation of macrophages by mAb against both subunits of CD11b/CD18 (25) . Treatment of human monocytes with the anti-CDllb mAb 44 failed to stimulate hydrogen peroxide-generating capacity (H . G. Remold, unpublished results) or homotypic adhesion ; additional anti-CDllb/CD18 mAbs were not examined .
Human sialophorin (CD43), the surface molecule recognized by L10 mAb, is found on thymocytes, T lymphocytes, some B lymphocytes, neutrophils, monocytes, and platelets (6, 7) . It is a highly glycosylated acidic molecule (-60% carbohydrate), consisting of a COOH-terminal intracellular region subject to phosphorylation by protein kinase C (26), a single transmembrane region, and an extracellular region (27) . Sialophorin has one N-linked carbohydrate unit and 80-90 sialic acid-bearing 0-linked units, distributed, more or less uniformly, throughout the -235-amino acid extracellular region (27, 28) .
The present study is the first examination of sialophorin function in monocytes, but the role of sialophorin in lymphocyte function has received some attention. Surface CD43 is deficient and/or defective in lymphocytes of patients with the inherited immune deficiency Wiskott-Aldrich syndrome (5) . Sialophorin is thought to be a component of a pathway of T cell activation, since L10 mAb triggers proliferation of human T lymphocytes (6) . L10-induced lymphocyte proliferation is quantitatively comparable with lymphocyte proliferation induced by mAbs directed against CD3/TCR, and both processes are monocyte dependent and lead to increased surface expression of HLA-DR and IL-2-R (6). The putative natural ligand for CD43 is unknown. Two other anti-CD43 mAbs, BIB6 and E11B, induce IL-2 secretion by lymphocytes, synergize with PMA in inducing lymphocyte proliferation, and induce lymphocyte aggregation (4). Lymphocyte aggregation induced by these anti-CD43 mAbs, like the anti-CD43-induced monocyte aggregation documented in this study, requires the presence of Mg and is abrogated by anti-LFA-1 mAb (4). Brief incubation of lymphocytes with L10 mAb was shown to generate increased levels of diacyl glycerol, inositol phosphates, and intracellular Ca 2+, as well as conversion of protein kinase C from a soluble to a membrane-associated form (29) . All of these L10-induced events are known to be associated with protein kinase C activation in other systems (30) . Moreover, two of these early changes, increased levels of inositol phosphates and intracellular Cat+, were also demonstrated in monocytes treated with L10 (29) .
Since monocyte activation induced by L10 and IFN-y have multiple common characteristics, the possibility was considered that L10 acts via the IFN-y pathway. L10-induced release of IFN-y from lymphocytes is a highly unlikely explanation, first of all, because the cell populations were 395% monocytes. It is certain that IFN-y and L10 bind to different molecules, since the receptors for both have been sequenced (27, 31) . Most importantly, the more rapid appearance ofactivation-associated changes in L10-treated monocytes relative to IFN-y-treated monocytes provides strong evidence that L10 action does not depend on the IFN-y-R pathway.
Indeed, the documentation ofparallel changes in anti-CD43-treated lymphocytes and anti-CD43-treated monocytes, i.e., early signaling involving inositol phosphates, Ca 2+, and protein kinase C, and the appearance at later times of homotypic adhe-sion, suggest that the pathway of CD43 activation is independent ofmolecules, like the IFN-y-R and the TCR/CD3 complex, that are specific to only one of these cells . Cumulatively, these findings indicate that CD43 is the surface receptor of an independent pathway of activation of lymphocytes and macrophages ; the pathway has early events common to lymphocytes and monocytes and later events specific to each cell. Summary Treatment ofhuman monocytes for 24-48 h with the anti-CD43 mAb L10 caused five-to sevenfold stimulation of hydrogen peroxide-producing capacity, an established characteristic of activated monocytes. Peroxide-producing capacity induced by L10 antibody (1 .6 ± 0.3 nmol H202/wg DNA/h) was comparable with that induced by IFN-y (1.3 ± 0.4 nmol H202/Ag DNA/h), but appeared more rapidly (maximal at 24 h) than in the ON-y-treated monocytes (maximal at 48 h) .
Treatment of monocytes with L10 mAb also caused dramatic increase in aggregation (homotypic adhesion) . Induction of monocyte aggregation by L10 mAb required incubation for 1-8 h in the presence of Mgt+ and was abrogated by TA-1, an anti-LFA-1-a mAb. Thus, L10-induced monocyte activation proceeds via a Mgt+-requiring aggregation stage involving LFA-1. Whereas the extent of monocyte aggregation induced by L10 mAb and by IFN-y were comparable, the L10-induced aggregation occurred more rapidly (maximal at 8 h) than the IFN-y-induced aggregation (maximal at 24 h) . The more rapid appearance of aggregation and increased hydrogen peroxide capacity in L10-treated monocytes suggests that the 1,10-induced activation pathway is independent of IFN-y-and IFN-y-R dependent events . These findings suggest that the surface molecule CD43 is the receptor of an independent activation pathway that leads in lymphocytes to proliferation and in monocytes to activation .
